妊娠相关严重脓毒症或脓毒性休克患者的病死率及不良结局较年龄和合并症匹配的非妊娠女性降低
该回顾性队列研究利用美国全国住院患者样本(1998-2012年),纳入15-44岁严重脓毒症或脓毒性休克住院女性,比较妊娠相关与非妊娠患者的结局。共识别妊娠相关严重脓毒症或脓毒性休克5,968例,非妊娠严重脓毒症或脓毒性休克85,240例。妊娠相关患者粗病死率9.6%,低于非妊娠患者的16.8%;校正社会经济状况和种族后病死率比率为0.57(95%CI 0.52-0.62),进一步校正年龄和慢性合并症后分别为0.62(95%CI 0.57-0.68)和0.63(95%CI 0.57-0.68)。妊娠相关患者住院时间更短、死亡前住院时间更长、器官衰竭数量更少。作者认为妊娠相关严重脓毒症或脓毒性休克患者病死率和不良结局降低,不能仅由年龄或慢性合并症差异解释。
要点
- 妊娠相关严重脓毒症或脓毒性休克粗病死率9.6%,非妊娠女性16.8%。
- 校正社会经济状况和种族后病死率比率0.57(95%CI 0.52-0.62)。
- 进一步校正年龄和慢性合并症后病死率比率分别为0.62(95%CI 0.57-0.68)和0.63(95%CI 0.57-0.68)。
- 妊娠相关患者住院时间缩短0.83天(95%CI -1.32至-0.34天),器官衰竭数量比率0.95(95%CI 0.94-0.97)。
- 妊娠相关患者死亡前住院时间延长2.61天(95%CI 1.28-3.94天)。
适用人群与场景
- 纳入15-44岁育龄女性,1998-2012年因严重脓毒症或脓毒性休克住院,使用国际疾病分类第9版临床修改版代码识别。
- 数据来源为美国全国住院患者样本,为20%急性照护医院住院的分层样本。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本为美国全国住院患者样本,纳入妊娠相关严重脓毒症或脓毒性休克5,968例和非妊娠严重脓毒症或脓毒性休克85,240例。
- 主要终点粗病死率:妊娠相关组9.6%,非妊娠组16.8%。
- 校正社会经济状况和种族后病死率比率0.57(95%CI 0.52-0.62)。
- 序贯校正年龄后病死率比率0.62(95%CI 0.57-0.68),校正慢性合并症后病死率比率0.63(95%CI 0.57-0.68)。
- 妊娠相关组住院时间缩短0.83天(95%CI -1.32至-0.34天),死亡前住院时间延长2.61天(95%CI 1.28-3.94天),器官衰竭数量比率0.95(95%CI 0.94-0.97)。
证据类型、等级与局限
- 证据类型为回顾性队列研究;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为妊娠相关严重脓毒症或脓毒性休克患者病死率和不良结局降低,不能仅由年龄或慢性合并症差异解释;较不严重的脓毒症表现或妊娠的保护效应可能解释该差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Case fatality in pregnancy-associated severe sepsis or septic shock appears reduced compared with nonpregnant women with severe sepsis or septic shock. It remains unclear if this difference is due to pregnancy or better baseline health status, among others. Our study compared adverse outcomes of pregnancy-associated severe sepsis or septic shock with nonpregnant women with severe sepsis or septic shock while controlling for age and chronic comorbidities.
DESIGN: Retrospective cohort study.
SETTING: Nationwide Inpatient Sample, a stratified sample of 20% acute care hospital admissions in the United States. Each entry includes patient and hospital characteristics as well as International Classification of Diseases, 9th revision, Clinical Modification, diagnoses and procedures.
SUBJECTS: Women of childbearing age (15-44 yr) with severe sepsis or septic shock-related hospitalizations during 1998-2012 identified using International Classification of Diseases, 9th revision, Clinical Modification, codes.
OUTCOMES: Case fatality, hospital length of stay, length of stay until death, number of organ failures, rates of mechanical ventilation, and hemodialysis were compared in women according to pregnancy status, controlling for age, and chronic comorbidities.
MEASUREMENTS AND MAIN RESULTS: We identified 5,968 pregnancy-associated severe sepsis or septic shock and 85,240 nonpregnant women with severe sepsis or septic shock hospitalizations. Crude case fatality of pregnancy-associated severe sepsis or septic shock (9.6%) was lower than nonpregnant women with severe sepsis or septic shock (16.8%). The rate ratio for case fatality adjusted for socioeconomic status and race was 0.57 (95% CI, 0.52-0.62) while sequential adjustments for age and chronic comorbidities did not eliminate the association (rate ratio, 0.62 [95% CI, 0.57-0.68]) and 0.63 [95% CI, 0.57-0.68], respectively). Pregnancy-associated severe sepsis or septic shock was associated with shorter hospital length of stay (-0.83 d [95% CI, -1.32 to -0.34 d]), longer length of stay until death (2.61 d; [95% CI, 1.28-3.94 d]), and fewer organ failures (rate ratio, 0.95 [95% CI, 0.94-0.97]).
CONCLUSIONS: Case fatality and adverse outcomes are reduced in women with pregnancy-associated severe sepsis or septic shock compared with nonpregnant women with severe sepsis or septic shock, and this is not explained by differences in age or chronic comorbidities alone. A less severe presentation of sepsis or protective effect of pregnancy may account for the difference observed with pregnancy-associated severe sepsis or septic shock.
参考来源
- Kidson KM, Henderson WR, Hutcheon JA, et al. Case Fatality and Adverse Outcomes Are Reduced in Pregnant Women With Severe Sepsis or Septic Shock Compared With Age-Matched Comorbid-Matched Nonpregnant Women. Crit Care Med. 2018. PMID: 30096100. doi:10.1097/CCM.0000000000003348
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。